Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study

Ellery Altshuler; Raymond Richhart; William King; Mahmoud Aryan; Akash Mathavan; Akshay Mathavan; Keegan Hones; Daniel F. Leach III; Logan Pucci; Joshua Riklan; Pat Haley; Ilyas Sahin; Brian Ramnaraign; Sherise Rogers; Ibrahim Nassour; Steven Hughes; Thomas J. George; Jesus Fabregas

doi:10.18632/oncotarget.28491

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Addendum:

Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study

PDF | How to cite

Oncotarget. 2023; 14:971-971. https://doi.org/10.18632/oncotarget.28491

Metrics: PDF 330 views | ?

Ellery Altshuler¹, Raymond Richhart¹, William King¹, Mahmoud Aryan², Akash Mathavan³, Akshay Mathavan³, Keegan Hones³, Daniel F. Leach III^3,7, Logan Pucci¹, Joshua Riklan¹, Pat Haley¹, Ilyas Sahin^4,5, Brian Ramnaraign^4,5, Sherise Rogers^4,5, Ibrahim Nassour⁶, Steven Hughes⁶, Thomas J. George^4,5 and Jesus Fabregas^4,5

¹Department of Internal Medicine, University of Florida, Gainesville, FL 32610, USA
²Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
³University of Florida College of Medicine, Gainesville, FL 32610, USA
⁴Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL 32610, USA
⁵University of Florida Health Cancer Center, Gainesville, FL 32610, USA
⁶Division of Surgical Oncology, Department of Surgery, University of Florida, Gainesville, FL 32610, USA
⁷Department of Radiation Oncology, University of Florida Health, Gainesville, FL 32601, USA

Published: December 12, 2023

Copyright: © 2023 Altshuler et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: No funding was used for this publication.

Original article: Oncotarget. 2023; 14:351-357. DOI: https://doi.org/10.18632/oncotarget.28406.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28491

Publication Alerts

Addendum:

Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study